2m 2m 2m 2m 2m 2m 2m
Enzolytics (ENZC)
OTC
$0.0006$0.00 (0.00%)
Price as of Aug 21, 2026- $2.4MMarket Cap
- 0.00%1-Year Change
- BiotechnologyIndustry
Enzolytics (ENZC)
$0.0006$0.00 (0.00%)
ENZC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 752,588 | ||
30-Day Average Volume | 1,771,386 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | 0.00% | ||
3-Year Change | -98.38% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.8B | ||
Total Assets | $112,053.00 | ||
Market Cap | $2.4M | ||
Enterprise Value | $2.8M | ||
Period: QTR TTM FY | |||
Revenue | $15,350.00 | ||
Net Income | -$221,241.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$214,028.00 | ||
EBITDA | -$210,937.00 | ||
Net Working Capital | N/A | ||
EPS | -$5.00 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 183 | ||
P/B | -3 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||